Difference between revisions of "Part:BBa K203119"
(→Usage and Biology) |
m (→Usage and Biology) |
||
(7 intermediate revisions by 2 users not shown) | |||
Line 7: | Line 7: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
− | NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a transcription factor (TF) which regulates many different target genes resulting in the expression of various proteins. In most cell types (with the exception of B cells and Dentritic cells) NF-κB is bound to the Inhibitor of κB (IκB), which withhold NF-κB from entering the nucleus. When the cell becomes activated by an extra cellular stimluli, IκB is degraded and NF-κB can enter the nucleus. Within the nucleus NF-κB is able to enhance transcription of genes which are involved in immune response, cell proliferation or cell survival, depending on cell type and extra cellular stimuli | + | NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a transcription factor (TF) which regulates many different target genes resulting in the expression of various proteins. In most cell types (with the exception of B cells and Dentritic cells) NF-κB is bound to the Inhibitor of κB (IκB), which withhold NF-κB from entering the nucleus. When the cell becomes activated by an extra cellular stimluli, IκB is degraded and NF-κB can enter the nucleus. Within the nucleus NF-κB is able to enhance transcription of genes which are involved in immune response, cell proliferation or cell survival, depending on cell type and extra cellular stimuli. In many cells NF-κB regulates anti-apoptotic proteins (e.g. TRAF1/2) and therby preventing cell death. Therefore mutations of NF-κB resulting in a constitutively active form are often associated with unregulated cell proliferation and cancer. In macrophages the NF-κB signalling pathway could be activated by binding of bacterial lipopolysacchride (LPS). There NF-κB activation leads to secretion of cytokines which influence other lymphocytes. For references see [http://2009.igem.org/Team:Heidelberg/Eukaryopedia#Transcription_factors Eukaryopedia]. |
<!-- --> | <!-- --> | ||
Line 15: | Line 15: | ||
===Functional Parameters=== | ===Functional Parameters=== | ||
<partinfo>BBa_K203119 parameters</partinfo> | <partinfo>BBa_K203119 parameters</partinfo> | ||
− | NF-κB was induced with 2,5µM TNF-α in [http://2009.igem.org/Team:Heidelberg/Eucaryopedia#U2-OS] cells. Expression level was determined in [http://2009.igem.org/Team:Heidelberg/Measurement REU] by flow cytometry (3 experiments on different days, 3 replicates / wells per experiment) 10 hours after induction. | + | NF-κB was induced with 2,5µM TNF-α in [http://2009.igem.org/Team:Heidelberg/Eucaryopedia#U2-OS U2-OS] cells. Expression level was determined in [http://2009.igem.org/Team:Heidelberg/Measurement REU] by flow cytometry (3 experiments on different days, 3 replicates / wells per experiment) 10 hours after induction. Promoter was shown to be specific to NF-κB |
{| class="wikitable centered" border="0" rules="rows" style="border-color:white;" | {| class="wikitable centered" border="0" rules="rows" style="border-color:white;" | ||
|- | |- | ||
− | |[[Image:HD09_NFkB_31.png|thumb|none|350px|'''BBa_K203119 is a promoter induced approximately by 100% by TNF-α'''. [http://2009.igem.org/Team:Heidelberg/Measurement REU] was determined by flow cytometry, 3 experiments à three replicates]] | + | |[[Image:HD09_NFkB_31.png|thumb|none|350px|'''Figure 1: BBa_K203119 is a promoter induced approximately by 100% by TNF-α'''. [http://2009.igem.org/Team:Heidelberg/Measurement REU] was determined by flow cytometry, 3 experiments à three replicates]] |
− | |[[Image:HD09_microscopy_NIIL10timepoints.PNG|thumb|none|350px|'''Timecourse of induction'''. Measured by image analysis. See [http://2009.igem.org/Team:Heidelberg/Project_Measurement#Flow_Cytometry/Fluorescence_Microscopy discussion] for why the results obtained by the two methods deviate.]] | + | |[[Image:HD09_microscopy_NIIL10timepoints.PNG|thumb|none|350px|'''Figure 2: Timecourse of induction'''. Measured by image analysis. See [http://2009.igem.org/Team:Heidelberg/Project_Measurement#Flow_Cytometry/Fluorescence_Microscopy discussion] for why the results obtained by the two methods deviate.]] |
|- | |- | ||
+ | |[[Image:1210 U2os cross.png|thumb|none|350px|'''Figure3: BBa_K203119 responds only to TNF-α and is not induced by other conditions'''. U2-OS Cells transfected with BBa_K203119 in BBa_K203100 were subjected to a variety of conditions (full medium DMEM+++, full medium lacking growth factors / serum DMEM++, starvation by minimal medium and [http://2009.igem.org/Team:Heidelberg/Eucaryopedia#HIF-1 pPARγ] induction by Thiazolidinedione) and did not show any significant induction or repression.]] | ||
+ | |[[Image:HD09_nfkappa_onoff.jpg|thumb|none|350px|'''Figure 4: BBa_K203119 is only active if NF-κB is localized to the nucleus'''. Cell were cotransfected with BBa_K203119 in [[Part:BBa_K203100]] and a p65-mcherry-fusion protein (kind gift of N. Brady, BioQuant). Only if the red fluorescence is localized to the nucleus, bright green fluorescence can be observed.]] | ||
|} | |} | ||
<!-- --> | <!-- --> |
Latest revision as of 08:59, 21 October 2009
NfKB Responsive promoter
A synthetic promoter upregulated by NF-κB activation. Manufactured by [http://2009.igem.org/Team:Heidelberg/Project_Synthetic_promoters RA-PCR].
Usage and Biology
NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a transcription factor (TF) which regulates many different target genes resulting in the expression of various proteins. In most cell types (with the exception of B cells and Dentritic cells) NF-κB is bound to the Inhibitor of κB (IκB), which withhold NF-κB from entering the nucleus. When the cell becomes activated by an extra cellular stimluli, IκB is degraded and NF-κB can enter the nucleus. Within the nucleus NF-κB is able to enhance transcription of genes which are involved in immune response, cell proliferation or cell survival, depending on cell type and extra cellular stimuli. In many cells NF-κB regulates anti-apoptotic proteins (e.g. TRAF1/2) and therby preventing cell death. Therefore mutations of NF-κB resulting in a constitutively active form are often associated with unregulated cell proliferation and cancer. In macrophages the NF-κB signalling pathway could be activated by binding of bacterial lipopolysacchride (LPS). There NF-κB activation leads to secretion of cytokines which influence other lymphocytes. For references see [http://2009.igem.org/Team:Heidelberg/Eukaryopedia#Transcription_factors Eukaryopedia].
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Functional Parameters
NF-κB was induced with 2,5µM TNF-α in [http://2009.igem.org/Team:Heidelberg/Eucaryopedia#U2-OS U2-OS] cells. Expression level was determined in [http://2009.igem.org/Team:Heidelberg/Measurement REU] by flow cytometry (3 experiments on different days, 3 replicates / wells per experiment) 10 hours after induction. Promoter was shown to be specific to NF-κB